Spondyloarthritis & psoriatic arthritis

Sex‐Related Differences in Efficacy and Safety Outcomes in Axial Spondyloarthritis Randomized Clinical Trials: A Systematic Literature Review and Meta‐Analysis

Arthritis Care Res (Hoboken)Published Systematic review and meta-analysis of randomised trials

Pooled result · ASAS40 response, all advanced therapiesResult — go to the resultOdds ratio 1.88 95% CI 1.44–2.46

Authors' conclusion

Female patients with axSpA are less likely to achieve efficacy outcomes on advanced therapies compared to their male counterparts, with similar differences across medication classes.

Study context

Population
Patients with axial spondyloarthritis (axSpA) in randomized controlled trials (RCTs) of advanced therapies (literature search until March 19, 2023)
Participants
23,748 patients79 RCTs
Comparison
Male vs female patients with axSpA on advanced therapies
Outcome
ASAS40 response, men vs women
Methodological detailsrandom-effects models
  • Random-effects models

Pooled result

ASAS40 response, all advanced therapies

Odds ratio

1.88

95% CI 1.44–2.46

Malevs Female
OR 1.88 (95% CI 1.44–2.46)

As reported in the abstract

Further pooled results

OutcomeOR (95% CI)
ASDAS-LDA/ID, all advanced therapies2.19 (1.47–3.26)
OutcomeOR
ASAS40 response, by medication classMale vs Female · IL-17Ai1.82
ASAS40 response, by medication classMale vs Female · TNFi2.42
ASDAS-LDA/ID, by medication classMale vs Female · IL-17Ai2.08
ASDAS-LDA/ID, by medication classMale vs Female · TNFi2.42

ASAS40 response, by medication class

Male patients had numerically higher values for IL-17A/Fi

Baseline characteristics by sex

Women significantly older and had higher pain scores; men had higher CRP levels

Reporting by sex

Trials reporting baseline characteristics by sex
9 trials (11.4%)
Trials reporting efficacy end points by sex
22 trials (28%)
Trials reporting safety end points by sex
9 trials (11.4%)

Original publication

Sex‐Related Differences in Efficacy and Safety Outcomes in Axial Spondyloarthritis Randomized Clinical Trials: A Systematic Literature Review and Meta‐Analysis. Arthritis Care Res (Hoboken). Published 19 March 2025. doi:10.1002/acr.25512

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.